Stocknear Logo Stocknear
ctrl K
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
  • Login
    Stocknear Logo Stocknear
    Start new chat
    Home
    Hedge Funds
    News
    Pricing Plan

    Apellis Pharmaceuticals I... (APLS)

    NASDAQ: APLS · Real-Time Price · USD
    19.11
    2.18 (12.88%)
    At close: Jun 02, 2025, 3:59 PM
    19.08
    -0.13%
    After-hours: Jun 02, 2025, 07:58 PM EDT
      Overview Financials Statistics Metrics Forecast Dark Pool Options Insider Dividends History Profile
      Insider Trading 13F Institute Transcripts

    Transcripts

    Pro Subscription

    Upgrade now for unlimited access to all data, tools and no ads.

    APLS News

    • 14 days ago - Apellis Pharmaceuticals: Have Some Patience - seekingalpha.com
    • 26 days ago - Apellis' Q1 Earnings and Revenues Miss Estimates, Stock Down - zacks.com
    • 26 days ago - Why Apellis Pharmaceuticals Wilted on Wednesday - fool.com
    • 26 days ago - Apellis Pharmaceuticals, Inc. (APLS) Q1 2025 Earnings Call Transcript - seekingalpha.com
    • 27 days ago - Apellis Pharmaceuticals (APLS) Reports Q1 Earnings: What Key Metrics Have to Say - zacks.com
    • 27 days ago - Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Lags Revenue Estimates - zacks.com
    • 35 days ago - Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - zacks.com
    • 62 days ago - APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag - zacks.com
    • 62 days ago - FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals - benzinga.com
    • 89 days ago - Apellis Pharmaceuticals: A Mixed Bag - seekingalpha.com

    Add to Watchlist

    Sections

    • Stocks
    • IPOs
    • ETFs
    • Blog

    Services

    • Pricing Plan
    • Discord Bot
    • Free Newsletter
    • Get Support

    Website

    • Login
    • FAQ
    • Sitemap
    • Learning Center
    • Affiliate Program

    Company

    • About
    • Contact Us
    • Terms of Use
    • Privacy Policy
    • Data Disclaimer
    • Imprint

    © 2025 Stocknear. All rights reserved.